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Abstract
To investigate the phenotypic and genetic overlap between anxiety and depression symp-
toms in an admixed population from extended family pedigrees. Participants (n = 1,375)
were recruited from a cohort of 93 families (mean age±SD 42±16.3, 57% female) in the rural
town of Baependi, Brazil. The Hospital Anxiety and Depression Scale (HADS) was used to
assess depression and anxiety symptoms. Heritability estimates were obtained by an
adjusted variance component model. Bivariate analyses were performed to obtain the parti-
tion of the covariance of anxiety and depression into genetic and environmental compo-
nents, and to calculate the genetic contribution modulating both sets of symptoms. Anxiety
and depression scores were 7.49±4.01 and 5.70±3.82, respectively. Mean scores were
affected by age and were significantly higher in women. Heritability for depression and anxi-
ety, corrected for age and sex, were 0.30 and 0.32, respectively. Significant genetic correla-
tions (ρg = 0.81) were found between anxiety and depression scores; thus, nearly 66% of
the total genetic variance in one set of symptoms was shared with the other set. Our results
provided strong evidence for a genetic overlap between anxiety and depression symptoms,
which has relevance for our understanding of the biological basis of these constructs and
could be exploited in genome-wide association studies.
Introduction
The National Comorbidity Study in the US estimated that depressive disorder has a lifetime
prevalence of approximately 16%, making it one of the most frequently diagnosed psychiatric
disorders [1]. By 2020, major depressive disorder is projected to be the second leading cause
of disability worldwide [2]. Anxiety disorders have a lifetime prevalence estimated to be as
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high as 18%; thus, they are also one of the most frequent psychiatric diseases in the general
population [1].
Depressive and anxiety disorders have a complex etiology, involving both genetic and envi-
ronmental factors. Heritability estimates range between 31% to 42% for major depressive disor-
der and between 20% to 40% for anxiety disorder [3, 4]. An important issue in the search for
risk factors of anxiety and depressive disorders is the frequent co-morbidity between those phe-
notypes [5]. Depression and anxiety symptomatology are strongly linked [1, 6, 7], and the co-
morbidity between those disorders results in lower social competence, in addition to more
severe symptoms than those patients diagnosed with a single disorder [8].
One way to uncover additional information about the relationship between anxiety and
depression is to examine the extent of shared genetic factors that influence these traits. Studies
investigating the heritability of combined depression and anxiety disorders published to date
have been based on twin samples mostly of European ancestry and, have shown a high genetic
correlation between anxiety disorders and major depression [5]. An alternative approach that
can aid in the identification of genetic susceptibility factors in those disorders is phenotypic
variation. Depressive and anxiety disorders can be conceptualized as extreme diagnostic enti-
ties in a continuum of varying severity. Therefore, instead of relying on categorical phenotypes
only, quantitative analysis of depressive and anxiety symptomatology can also improve the
detection of meaningful genetic risk markers [9]. Indeed, heritability estimates were indepen-
dently obtained from twin studies in the Netherlands and Australia showing that a common
genetic factor is responsible for most of the variance in the phenotypic presentation of com-
bined anxiety and depressive symptoms in the general population [10, 11].
The current study used the Hospital Anxiety Depression Scale (HADS) [12] to examine the
heritability and shared genetic factors between symptoms of anxiety and depression from large
extended families of a population that is highly admixed, mainly along the axis between Euro-
pean and African ancestry. The population chosen, the Baependi Heart Study cohort [13], is
uniquely suited to our study purpose. Located in a rural town in Brazil (18,307 inhabitants
recorded in the 2010 census), the study population is remarkably homogeneous in terms of
their lifestyle, which remains very traditional. Thus, the ethnic background, living conditions,
and family-based study design representing large and complex pedigrees, offer potential novel
insights into the biology and genetic basis of depression and anxiety as well as other behavior
traits [14].
Materials and Methods
Participants
This study included 1,375 individuals (57% female) belonging to extended pedigrees (95 fami-
lies) aged 18–98 (mean ± SD = 42.52 ± 16.28) from the Baependi Heart Study, a genetic epide-
miological study with a longitudinal design, who provided valid data to this study. The
pedigrees had mean size of 24.15 ± 31.79 members and were from 3 to 4 generations in their
majority (63%). There were 640 sibships with mean size of 2.45 ± 1.87 and the following num-
bers of main pairs of relatives were: parent/offspring– 3138; sibling/sibling– 2253; grandpar-
ent/grandchild– 2590; avuncular– 4418; half siblings– 40; and cousins: 3743. Further
characteristics of the population and the sampling methodology have been described previ-
ously [13]. 6.4% (n = 88) of the participants were using antidepressant medication at the time
of the interview. Subjects with cognitive impairments were not included. The authors assert
that all procedures contributing to this work comply with the ethical standards of the relevant
national and institutional committees on human experimentation and with the Helsinki Decla-
ration of 1975, as revised in 2008. The study protocol was approved by Ethics committee of the
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Hospital das Clínicas, University of São Paulo, Brazil. Participation in the study was voluntary,
and each volunteer provided informed written consent before participation. For illiterate par-
ticipants or for those without the capacity to sign, the consent term was completely read by a
researcher in the presence of an authorized representative of the volunteer, usually a relative,
who signed the authorization according to the participant decision. Data were collected
between December 2005 and January 2006.
Instruments
Symptoms of depression and anxiety were assessed using a Portuguese translation of the
HADS questionnaire made and validated for use in Brazil [15]. The scale consists of 14 self-
administered items, with seven questions relating to anxiety and the other seven to depression
[16]. The questions are based on a four-point Likert scale with scores ranging from 0 to 3.
The Portuguese version of HADS has previously been shown to be easy to understand, and to
have a high sensitivity and specificity [17]. The questionnaire was completed by the partici-
pants in the permanent field station of the Baependi project, and was read in its entirety by the
researcher acting as a scribe to participants with an insufficient level of literacy.
Statistical analysis
Comparisons among general characteristics were performed with SPSS 20 for Windows (IBM,
Armonk, NY). Continuous variables like HADS scores were tested using ANOVA, and for
dichotomous variables such as sex and age category differences, the chi-square test was used.
The variance component model is a well-known tool for heritability estimates in family studies
and was used to calculate polygenic heritability estimates [18]. In the most narrow sense, the
heritability of a trait represents the proportion of the phenotypic variance attributable to addic-
tive genetic effects and is given by h2 = σ2a/ σ
2
p, where σ
2
a is the variance due to the addictive
effects of genes, and σ2p is the phenotypic variance. The overall phenotypic variance was esti-
mated from the observed distribution of trait values in the sample, and was partitioned into
genetic and environmental components using the observed covariance among family members,
asΩ = 2fσ2a + Iσ
2
e, where Ω is an “n x n” matrix of the “n” individuals in the data set, 2f is
the structuring matrix of the coefficient of relationship, and “I” is an identity matrix that
represents the structuring matrix for σ2e, the variance due to residual environmental factors.
Estimates of the mean and variance components were obtained using maximum likelihood
methods [19, 20].
Joint analysis of multiple related phenotypes can be used to answer questions about the
nature of the relationship between the traits and to increase power to localize genes influencing
the traits [21, 22]. In this context, in the bivariate model, the genetic correlations (ρg) and envi-
ronmental correlations (ρe) represent the additive polygenic effect of shared genes or common
genetic effects on the two traits (pleiotropy) and environmental factors (non-genetic) in the
phenotypic variance of each trait, respectively. The overall phenotypic correlation (ρp) between
two traits can be broken down into a genetic and environmental component:
rp ¼ rg
ﬃﬃﬃﬃ
h21
p ﬃﬃﬃﬃ
h22
p þ re ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1# h21p ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1# h22p ð1Þ
In this correlation, h21 and h
2
2 are the heritabilities in trait 1 and trait 2. Using this nomencla-
ture, the proportion of the total genetic variance that is due to shared genetic effects is esti-
mated by the square of the genetic correlation (ρg). Likelihood ratio tests were used to
separately test the hypotheses that the two traits share no common genetic basis (H0:ρg = 0)
and that the two traits have the identical genetic basis (H0:|ρg| = 1).
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In this study, the heritability of HADS-A and HADS-D as well as bivariate genetic correla-
tions were conducted using the maximum likelihood estimate based variance components
approach implemented in the statistical genetics software package, SOLAR [21]. Four models
were fitted to the data: (1) unadjusted, (2) adjusted by age, (3) adjusted by gender and (4)
adjusted by age and gender. In each adjusted model, the estimates of the parameters in question
were calculated.
Results
Description of the sample
Socio-demographic characteristics of the sample are given in Table 1. All age categories were
represented and there was no gross difference between genders. 62.9% of subjects were married
or living with a partner. 41.6% of the sample had four years or less of schooling, and 86.4% of
the sample had a monthly household income of less than R$1,500. No more than 1% of any
used variable was missing.
HADS values
The following coefficients of internal consistency (Cronbach’s alpha) were obtained: anxiety (α
= 0.74), depression (α = 0.73), and total score (α = 0.83). Anxiety and depression were corre-
lated with r = 0.59 (Pearson, p<0.0001) and r = 0.58 (Spearman's ρ, p<0.0001). Similar signifi-
cant results were obtained when the sample was divided by gender: For males, r = 0.54, and for
females, r = 0.59.
The mean scores and standard deviations in the HADS-A and HADS-D scale for the total
population were 7.49±4.01 and 5.70±3.82, respectively, with responses ranging from 0 to 21.
Women reported higher scores than men for anxiety symptoms (F = 53.32 p = 0.001). This
gender difference persisted for depressive symptoms, but to a lesser degree (F = 40.57
p = 0.001). Age differences were noted in both anxiety (F = 4.02 p = 0.003) and depression
(F = 13.19 p = 0.001). HADS-A and HADS-D mean scores increased with age until reaching
their peak in the range of 40 to 59 years of age as illustrated in Figs 1 and 2, respectively.
Heritability
Heritability estimates for HADS-A and HADS-D are shown in Table 2. Estimates were similar
in the various adjusted models and were all statistically significant (p<0.0001). Heritability,
without taking covariates into account (unadjusted model), was 0.28 for HADS-D and, 0.30 for
HADS-A. When corrected for age and sex, the numbers increased to 0.30 (HADS-D) and 0.32
(HADS-A). The significant effects of age and sex for both phenotypes indicate that there is an
increase in precision when these factors are accounted for. Thus, we also divided the sample
into an older and a younger age group, the cut-off point being the 50% percentile (41 years),
and ran a set of heritability estimates. A marked difference was found between these age
groups. The younger age group had higher heritability estimate compared to the older age
group for HADS-A (younger/older = 0.32/0.22) and, HADS-D scores (younger/older = 0.31/
0.18). The added inclusion of age2 and age x gender did not change the results of heritability
for any of the scores.
Bivariate analyses
Testing the null hypothesis that the genetic correlation between HADS-A and HADS-D mea-
sures was zero (that is, that there is no shared genetic basis between HADS-A and HADS-D)
resulted in highly significant P-values (< 10−6), and this hypothesis was therefore rejected
Anxiety and Depression Shared Genetics
PLOS ONE | DOI:10.1371/journal.pone.0144255 December 9, 2015 4 / 10
(data not shown). A second null hypothesis that the genetic correlation between these traits is
one (that is, the genetic bases HADS-A and HADS-D are identical) was also rejected as very
unlikely (P<10−4) (data not shown).
The overall phenotypic correlation (ρp) between HADS-A and HADS-D measures was bro-
ken down into a genetic (ρg) and environment (ρe) component according to Eq (1) described
in the Methods section. The genetic correlation between HADS-A and HADS-D measures ran-
ged from 0.78 to 0.81 through all models: the unadjusted, adjusted for gender, age, gender and
age and interaction age x gender (Table 3). The decomposition of the phenotypic correlation
revealed a stronger genetic than environmental correlation contribution to the overlap between
depression and anxiety symptoms in all models.
The proportion of the total genetic variance due to shared genetic effects is estimated by the
square of the genetic correlation, thus, in the best model, adjusted for gender and age, this pro-
portion is 0.812 = 0.66, suggesting that nearly 66% of the total genetic variance in HADS-A is
shared with HADS-D.
Discussion
In this study, we quantified the degree of shared genetic variance between anxiety and depres-
sion symptoms, assessed via the HADS-A and HADS-D sections, respectively, and also calcu-
lated estimates of heritability for the two sets of symptoms in a large sample of Brazilian
families.
Table 1. Socio-demographic characteristics of the sample.
Total Males Females
n % n % n %
Age category
18–29 years 370 26.9 158 26.9 212 26.9
30–39 years 258 18.8 109 18.6 149 18.9
40–49 years 314 22.8 129 22.0 185 23.5
50–59 years 208 15.1 88 15.0 120 15.2
&60 years 225 16.4 103 17.5 122 15.5
Marital status
Married or living together 865 62.9 375 63.9 490 62.2
Single 368 26.8 178 30.3 190 24.1
Divorced 60 4.4 17 2.9 43 5.5
Widowed 73 5.3 13 2.2 60 7.6
Education
' 4years 571 41.6 263 45.0 308 39.1
5–8 years 309 22.5 127 21.7 182 23.1
9–11 years 360 26.2 143 24.5 217 27.5
& 12 years 132 9.6 51 8.7 81 10.3
Household income a
Class E (Less than R$ 300.00) 249 18.7 100 17.5 149 19.6
Class D/C (R$ 300.00-R$ 1.500.00) 901 67.7 373 65.3 528 69.5
Class B (R$ 1.500.00-R$6.000.00) 172 12.9 93 16.3 79 10.4
Class A (More than R$ 6.000.00) 9 0.7 5 0.9 4 0.5
a Monthly Income in Brazilian Real
doi:10.1371/journal.pone.0144255.t001
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We found that approximately 66% of the genetic variance for HADS-A is shared with
HADS-D, and vice versa. These results suggest that the same genetic factors influence the sus-
ceptibility to anxiety and depressive scores. A similar methodology was applied by Olvera and
colleagues [23], who performed bivariate analyses in a family-based Mexican-American sample
Fig 1. Mean HADS-A scores across age categories.
doi:10.1371/journal.pone.0144255.g001
Fig 2. Mean HADS-D scores across age categories.
doi:10.1371/journal.pone.0144255.g002
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of shared genetic background between psychiatric disorders. That analysis found a strong
genetic correlation in individuals concomitantly diagnosed with anxiety and depressive disor-
ders (ρp>0.75). Shared genetic correlations between anxiety and depressive symptoms have
consistently been found in twin studies but those studies have all been based on cohorts of pri-
marily European ancestry [10, 11]. Boomsma et al, 2000, in a study of Dutch adolescent and
young adult twins, found a common genetic factor that influenced more than 40% of the
variance explained by genetic factors for both depression and anxiety symptoms. Similarly,
Kendler et al, 1987, found a common genetic factor that influenced the susceptibility of the
concomitant presentation of depression and anxiety symptoms in an Australian adult twin
cohort. Thus, our findings are unique in reporting a shared genetic background between
the degree of anxiety and depression (as continuous variables) using the HADS scale in an
admixed population, and confirmatory with respect to previous reports of a shared genetic
background in comorbid symptoms seen in the general population in samples of mostly Euro-
pean ancestry.
The heritability estimates obtained in the present study were 0.30 HADS-D, and 0.32 for
HADS-A. In the literature, heritability estimates for depression range from 0.17 to 0.78 and for
anxiety from 0.25 to 0.60 [3, 24]. Heritability measures of anxiety and depression for this study
lie on the lower side of the range of studies investigating both disorders [3, 24]. Differences in
heritability estimates can be due to sample selection or experimental design. Those differences
can be the result of age and/or gender-specific genetic effects that impact on those estimates.
For example, we found in our very same cohort that individuals younger than 41 years old had
a heritability estimate of 0.32 for anxiety compared to 0.22 in the oldest subset. This could also
be the case in different samples with distinct age groups [25–27]. Despite methodological dif-
ferences between classical twin design and extended pedigree design, rendering distinct herita-
bility estimates, general results indicate that both are able to generate good estimates [28].
In order to discuss the relevance of our genetic findings, it is important to address particu-
larities and possible limitations of the sample and study design. We found a lower frequency of
Table 2. Heritability estimates.
Model h2gA p values h2gD p values
No adjustment 0.30±0.06 <0.0001 0.28±0.06 <0.0001
Gender 0.31±0.06 <0.0001 0.29±0.06 <0.0001
Age 0.34±0.06 <0.0001 0.29±0.05 <0.0001
Gender, age 0.35±0.06 <0.0001 0.29±0.60 <0.0001
Gender*age 0.33±0.06 <0.0001 0.29±0.60 <0.0001
h2g = heritability; A = anxiety scores; D = depression scores. Values are shown with standard deviation.
doi:10.1371/journal.pone.0144255.t002
Table 3. Bivariate analysis.
Model ρp p values ρg p values ρe p values
No adjustment 0.59 <0.0001 0.78±0.07 <0.0001 0.52±0.04 <0.0001
Gender 0.58 <0.0001 0.79±0.04 <0.0001 0.50±0.04 <0.0001
Age 0.60 <0.0001 0.80±0.07 <0.0001 0.51±0.04 <0.0001
Gender, age 0.58 <0.0001 0.81±0.07 <0.0001 0.48±0.04 <0.0001
Gender*age 0.50 <0.0001 0.81±0.07 <0.0001 0.50±0.04 <0.0001
ρp = phenotypic correlation; ρg = genetic correlation; ρe = environmental correlation. Values are shown with standard deviation for ρg and ρe.
doi:10.1371/journal.pone.0144255.t003
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symptoms of anxiety and depression in men compared with women, as reported in previous
studies world-wide [29, 30]. Studies performed in Brazil showed the same tendency [15, 17],
but were conducted in groups with health problems which tends to increase the HADS scores.
It is interesting to note that both the depression and anxiety mean scores found in our popula-
tion were higher than all the studies referred to above with exception to the Korean general
population study where depression results (mean = 6.6) showed higher mean scores than in
Baependi [31]. Possible explanations for higher scores in the Baependi population are the low
level of education and income in this population (Table 1). These are important covariates to
be considered, as low socio-economic status raises the odds for depression and anxiety and
decreasing family income over time increased vulnerability to the symptoms of anxiety and
depression [32, 33]. Educational level is one of the factors that comprises the socio-economic
status index, and seems to exert a protective effect to anxiety and depression disorders. In an
11-year follow up study, people with a low educational level (often resulting in professions
involving hard manual work) moved towards higher anxiety and depression scores when com-
pared to others with high level of schooling [34].
The inclusivity of our study, a distinguishing aspect of this study, could also be a reason for
the scores being higher than in other general population studies. All participants with valid
scores were included, independent of age (participants were aged up to 98), sex, use of medica-
tion, socio-economic status, and health condition. The subjectivity of self-assessment scales
like HADS, although extensively used in epidemiological studies, can be a potential source of
bias as well [26]. Ultimately, given the unique and in many ways advantageous features of this
study design (a highly admixed population living in a rural town with a very conservative life-
style), and some unique complications (e.g. a high level of illiteracy), it becomes difficult to
compare it with previous findings.
Conclusions
The finding of a high proportion of shared genetic factors between continuous measures of
depression and anxiety shows that the well-known clinical correlation between these systems is
reflected on a profound biological level. Furthermore, evidence for shared genetic effects has
promising implications for future molecular genetics studies, because they may increase power
to localize genes influencing these traits in genome-wide association studies [35].
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